论文部分内容阅读
目的:探讨甲泼尼松龙辅助治疗支原体肺炎的临床疗效以度免疫影响。方法:收集我院收治的100例支原体肺炎忠儿,随机分为观察组和对照组,各50例。对照患儿使用常规治疗方法进行治疗,观察组患儿在常规治疗的基础上使用甲泼尼松龙进行治疗。两组患儿在治疗完成后比较两组患儿的治疗效果以及血清CRP、IL-2、IL-8以及TNF-α水平。结果:两组患儿在经过治疗后均有所好转,但观察组患儿的治疗效果明显优于对照组怠儿,同时观察组患儿的血清CRP、IL-2、IL-8水平明显低于对照组患儿,TNF-α水平明显高于对照组患儿。结论:甲波尼松龙能够在实际的对支原体肺炎患儿进行治疗的过程中起到较好的效果,同时显著的改变血清CRP、IL-2、IL-8以及TNF-α水平,在临床上值得推广应用。
Objective: To investigate the clinical effect of methylprednisolone adjuvant treatment of mycoplasma pneumonia in order to measure the immune effect. Methods: One hundred cases of Mycoplasma pneumonia were collected from our hospital and randomly divided into observation group and control group, 50 cases each. The control children were treated by conventional treatment. The observation group was treated with methylprednisolone on the basis of routine treatment. After treatment, the two groups of children were compared the therapeutic effect of two groups of children as well as serum levels of CRP, IL-2, IL-8 and TNF-α. Results: Both groups improved after treatment, but the treatment effect in observation group was better than that in control group. The levels of serum CRP, IL-2 and IL-8 in observation group were significantly lower In control group, TNF-αlevel was significantly higher than that in control group. Conclusion: Neononetine can play a good role in the actual treatment of children with mycoplasmal pneumonia, while significantly changing the serum levels of CRP, IL-2, IL-8 and TNF-α in the clinical On the worth of promotion.